About CarthaGenetics®

Philippe Carteron , 40 years old, senior consultant and CEO

Philippe brings you a 15-year + experience in the pharmaceutical industry, with backgrounds in both biology and marketing applied to pharmaceuticals. For companies like Genzyme and TKT, Philippe had to set up the right European channels required for patients' reimbursement and for the market development of orphan disease drugs in the field of rare genetic disorders.
Moreover, Philippe has initiated and established the necessary North African channels, structures and processes for both Genzyme and TKT. Such processes have made possible patient access to the most innovative treatments in the North African region, despite high development costs well-known in the pharmaceutical industry.